The catalytic asymmetric aminooxygenation of olefins is a very important process due to the significance of the products as building blocks in the synthesis of drugs and natural products.1 The enantioselective intermolecular osmium-catalyzed aminohydroxylation developed by Sharpless and co-workers has proven to be an extremely useful method, as exemplified by its use in numerous syntheses of biologically active compounds.2 Surprisingly, an enantioselective intramolecular olefin aminooxygenation, which would result in the direct synthesis of chiral nitrogen heterocycles, has not previously been reported. While regio- and diastereoselective intramolecular osmium-3 and palladium-catalyzed4 olefin aminooxygenation reactions have been reported, no successful ligand-based asymmetric variants have been disclosed.5 Herein we report a novel and mechanistically distinct copper-catalyzed enantioselective intramolecular aminooxygenation of olefins.5f This method allows for the synthesis of chiral indolines and pyrrolidines, common components in biologically active molecules.
We recently reported an enantioselective copper-catalyzed intramolecular carboamination of olefins which results in the synthesis of chiral sultams.6 Mechanistic analysis of the racemic, copper-promoted version of this reaction indicated the presence of a primary carbon radical species that was trapped with tetramethylaminopyridyl radical (TEMPO) in excellent yield (cf 1 → 2).7 This process, signifying a net aminooxygenation reaction, inspired us to ascertain whether a catalytic enantioselective variant could be achieved.
Our study commenced by adding TEMPO (3 equiv) to the optimal catalytic enantioselective carboamination reaction conditions, which uses MnO2 as stoichiometric oxidant (Table 1, entry 1). Upon further examination we found that TEMPO alone could be used for copper turnover [Cu(I) to Cu(II)]. As shown in Table 1, the yield and enantioselectivity both increased upon removal of additional oxidants (entry 3). A variety of other nitrogen protecting groups were also surveyed (Table 1, entries 4–6). The tosyl group proved superior to the unreactive methyl sulfonamide, benzamide and carbamate.
Table 1.
Oxidant and N-substituent screena
![]() | ||||
|---|---|---|---|---|
| entry | R | oxidant | yieldb (%) | %eec |
| 1 | 1a, R = Ts | MnO2 (3 eq) | 71 | 72 |
| 2 | 1a | O2 (1 atm) | 96 | 81 |
| 3 | 1a | - | 97 | 83 |
| 4 | 1b, R = SO2Me | - | NR | - |
| 5 | 1c, R = Bz | - | NR | - |
| 6 | 1d, R = Cbz | - | NR | - |
Conditions: Cu(OTf)2 (0.2 equiv) and ligand (0.2 equiv) were combined, dissolved in PhCF3 (0.07 M w/r to 1) and heated at 50 °C for 2 h. Substrate 1 (1 equiv), oxidant, TEMPO (3 equiv) and K2CO3 (1 equiv) were added. The reaction was heated at 110 °C for 24 h.
Yield refers to amount of isolated 2 after purification by flash chromatography on SiO2.
Enantiomeric excesses were determined by chiral HPLC analysis [Chiralcel (S,S) Whelk]. NR = No reaction.
Our next objective was to identify an optimal ligand for asymmetric induction (Table 2). An early screen of commercially available bisoxazoline ligands revealed that the 5-phenyl substitution pattern is essential. Other aryl substituents such as 2-naphthalene,8 as well as cis and trans 4,5-disubstituted phenyl bisoxazoline derivatives9 were also examined. When used in slight excess, both antipodes of the 4,5-cis-diphenyl bisoxazoline ligand were optimal (entries 5 and 6).
Table 2.
Chiral ligand screena
![]() | ||||
|---|---|---|---|---|
| entry | ligand(equiv) | yieldb (%) | %ee(config)c | |
| 1 | R = (S,S)-Phbox (0.2) | 97% | 83% (R) | |
| 2 | R = (S,S)-2-Napthbox (0.2) | 47% | 43% (R) | |
| 3 | R = (4R,5R)-Bis-Phbox (0.2) | 97% | 77% (S) | |
| 4 | R = (4S,5R)-Bis-Phbox (0.2) | 97% | 88% (S) | |
| 5 | R = (4R,5S)-Bis-Phbox (0.25) | 97% | 84% (R) | |
| 6 | R = (4S,5R)-Bis-Phbox (0.25) | 97% | 90% (S) | |
Conditions: Cu(OTf)2 (0.2 equiv) and ligand were combined, dissolved in PhCF3 (0.07 M w/r to 1a) and heated at 50 °C for 2 h. Substrate 1a (1 equiv), TEMPO (3 equiv) and K2CO3 (1 equiv) were added. The reaction was heated at 110 °C for 24 h.
Same as Table 1.
The generality of the reaction was examined as shown in Table 3. N-Sulfonyl-2-allyl aniline substrates 1 cyclized in 57 – 97% yield providing indolines 2 in 50 – 91% ee. A variety of functional groups on the aniline were tolerated with the exception being a slight decrease in ee for the electron withdrawing nitrile 1i.
Table 3.
Scope of Enantioselective Aminooxygenation with (1S,2R)-Bis-Phbox liganda
| entry | substrate | Product | yield(%)d | ee(%)e |
|---|---|---|---|---|
![]() |
![]() |
|||
| 1 | 1a, R1 = H, R2 = Ts | 2a | 97 | 90 |
| 2 | 1e, R1 = p-F, R2 = Ts | 2e | 83 | 89 |
| 3 | 1f, R1 = p-Cl, R2 = Ts | 2f | 73 | 91 |
| 4 | 1g, R1 = p-OMe, R2 = Ts | 2g | 82 | 86 |
| 5 | 1h, R1 = p-Me, R2 = Ts | 2h | 75 | 85 |
| 6 | 1i, R1 = p-CN, R2 = Ts | 2i | 88 | 76 |
| 7 | 1j, R1 = m-OMe, R2 = Ts | 2j | 61 | 87 |
| 8 | 1k, R1 = H, R2 = Ns | 2k | 75 | 61 |
| 9 | 1b, R1 = H, R2 = Ms | 2b | 57 | 50 |
![]() |
![]() |
|||
| 10b | 3a, R1 = Me, R2 = Ts | 4a | 97 | 88f |
| 11b | 3b, R1 = Ph, R2 = Ts | 4b | 97 | 92 |
| 12b | 3c, R1 = −CH2O(Si(tBu)2)OCH2−, R2 = Ts | 4c | 87 | 89 |
| 13b | 3d, R1 = −CH2O(CH3)2OCH2−, R2 = Ts | 4d | 88 | 89 |
| 14c | 3e, R1 = H, R2 = Ts | 4e | 74 | 75 |
| 15c | 3f, R1 = Me, R2 = Ns | 4f | 86 | 89 |
![]() |
![]() |
|||
| 16c | 5 | 6 | 61 | 82 |
Conditions: Cu(OTf)2 (0.2 equiv) and ligand (0.25 equiv) were combined, dissolved in PhCF3 (0.07 M w/r to substrate) and heated at 50 °C for 2 h. Substrate (1 equiv), TEMPO (3 equiv) and K2CO3 (1 equiv) were added. The reaction was heated at 110 °C for 24 h.
Reaction was run at 120 °C under O2 (1 atm).
0.4 equiv of Cu(OTf)2 and 0.5 equiv of ligand were used.
Yield refers to amount of isolated product after purification by flash chromatography on SiO2.
Enantiomeric excess were determined by chiral HPLC analysis. Each reaction was run at least 2 times.
A range of 86–90% ee was obtained.
The nature of the sulfonamide significantly effects the enantioselectivity where the tosyl was superior to the mesyl substrate 1b (Table 1, entry 4) and the nosyl substrate 1k (Table 3, compare entries 1,8, and 9). Worth noting, ortho substituted aniline derivatives (R = OMe, Cl) were unreactive.
The 4-pentenylamine substrates 3 cyclized in 74–97% yield providing pyrrolidines 4 in 75–92% ee (entries 10–16).10 O2 (1 atm) as a co-oxidant was necessary in order to drive these reactions to completion. The unsubstituted aliphatic substrate 3e, nosylate 3f, and the 1,1-disubstituted olefin substrate 5 all required higher catalyst loading in order to obtain an appreciable yield and ee (Table 3, entries 14–16). In the latter case, chiral tertiary amine 6 is formed in good enantioselectivity. The reaction of the nosylate 3f (86% yield, 89% ee) is notable since this sulfonyl group is easier to remove than the corresponding tosylate.11
The absolute configuration was assigned by conversion of 2a and 4e to their corresponding known chiral N-tosyl amino alcohols (Scheme 1 and supporting information). The observed stereochemistry is consistent with a proposed transition state model where the substrate’s N-substituent is trans to the nearest oxazoline’s phenyl groups (Scheme 1).6,12 The TEMPO adduct 4a was converted to the aminoalcohol13 7 and oxidized to aldehyde14 8 without diminished enantioselectivity (Scheme 1). Furthermore, removal of the tosyl group followed by TEMPO reduction provided the known chiral amino alcohol 9.15
Scheme 1.
Transition state model and TEMPO functionalization
This aminooxygenation method provides efficient access to a variety of chiral pyrrolidines and indolines of interest to synthetic organic and medicinal chemists. Its further optimization and application towards the syntheses of such compounds is underway.
Supplementary Material
Experimental procedures and compound characterization are available free of charge via the internet at http://www.pubs.acs.org.
Acknowledgement
Financial Support from the National Institutes of Health/NIGMS RO1 GM078383 is gratefully acknowledged.
References
- 1.Bergmeier SC. Tetrahedron. 2000;26:2561. [Google Scholar]
- 2.Reviews of aminohydroxylation processes: O’Brien P. Angew. Chem. Int. Ed. Engl. 1999;38:326. Bolm C, Hildebrand JP, Muniz K. In: Catalytic Asymmetric Synthesis. 2nd ed. Ojima I, editor. Wiley-VCH; 2000. pp. 412–424. Schlingloff G, Sharpless BK. In: Asymmetric Oxidation Reactions. Katsuki T, editor. Oxford University Press; 2001. pp. 104–114. Nilov D, Reiser O. Adv. Synth. Catal. 2002;344:1169. Bodkin JK, McLeod MD. J. Chem. Soc. Perkin Trans. 1. 2002:2733.
- 3.(a) Donohoe TJ, Churchill GH, Wheelhouse KMP, Glossop PA. Angew. Chem. Int. Ed. Engl. 2006;45:8025. doi: 10.1002/anie.200603240. [DOI] [PubMed] [Google Scholar]; (b) Donohoe TJ, Chughtai MJ, Klauber DJ, Griffin D, Campbell AD. J. Am. Chem. Soc. 2006;128:2514. doi: 10.1021/ja057389g. [DOI] [PubMed] [Google Scholar]; (c) Donohoe TJ, Bataille CJR, Gattrell W, Kloeges J, Rossignol E. Org. Lett. 2007;9:1725. doi: 10.1021/ol070430v. [DOI] [PubMed] [Google Scholar]
- 4.(a) Alexanian EJ, Lee C, Sorensen EJ. J. Am. Chem. Soc. 2005;127:7690. doi: 10.1021/ja051406k. [DOI] [PubMed] [Google Scholar]; (b) Szolcsanyi P, Gracza T. Chem. Commun. 2005:3948. doi: 10.1039/b506731f. [DOI] [PubMed] [Google Scholar]; (c) Desai LV, Sanford MS. Angew. Chem. Int. Ed. 2007;46:5737. doi: 10.1002/anie.200701454. [DOI] [PubMed] [Google Scholar]
- 5.For other intramolecular aminooxygenation reactions, see: Noack M, Gottlich R. Chem. Commun. 2002:536. doi: 10.1039/b111656h. Chikkanna D, Han H. Synlett. 2004:2311. Correa A, Tellitu I, Dominguez E, SanMartin R. J. Org. Chem. 2006;71:8316. doi: 10.1021/jo061486q. Cochran BM, Michael FE. Org. Lett. 2008;10:5093. doi: 10.1021/ol702891p. Mahoney JM, Smith CR, Johnston JN. J. Am. Chem. Soc. 2005;127:1354. doi: 10.1021/ja045608c. (f) for recent copper and palladium-catalyzed intermolecular aminooxygenation reactions, see supporting information.
- 6.Zeng W, Chemler SR. J. Am. Chem. Soc. 2007;129:12948. doi: 10.1021/ja0762240. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Sherman ES, Fuller PH, Kasi D, Chemler SR. J. Org. Chem. 2007;72:3896. doi: 10.1021/jo070321u. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.vanLingen HL, vanDelft LF, Storcken RPM, Hekking KFW, Klaasen A, Smits JJM, Ruskowska P, Frelek J, Rutjes FPJT. Eur. J. Org. Chem. 2005:2975. [Google Scholar]
- 9.Desimoni G, Faita G, Mella M. Tetrahedron. 1996:13649. [Google Scholar]
- 10.N-Tosyl-2-allyl-benzylamine did not provide the corresponding 6- membered ring aminooxygenation product.
- 11.Kan T, Fukuyama T. Chem. Commun. 2004:353. doi: 10.1039/b311203a. [DOI] [PubMed] [Google Scholar]
- 12.A discussion of the C-O bond forming mechanism is provided in the supporting information.
- 13.Sheldrake HM, Wallace TM. Tet. Lett. 2007;48:4407. [Google Scholar]
- 14.Inokuchi T, Kawafuchi H. Tetrahedron. 2004;60:11969. [Google Scholar]
- 15.Compound 9, an intermediate en route to a chiral ligand, was previously synthesized in a more lengthy sequence from L-glutamic acid: Nakagawa Y, Kanai M, Nagaoka Y, Tomioka K. Tetrahedron. 1998;54:10295.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Experimental procedures and compound characterization are available free of charge via the internet at http://www.pubs.acs.org.









